Prati
Marcus Maurer
Marcus Maurer
Professor, Institute of Allergology, Charité - Universitätsmedizin Berlin, Germany
Potvrđena adresa e-pošte na charite.de - Početna stranica
Naslov
Citirano
Citirano
Godina
Allergic rhinitis and its impact on asthma
J Bousquet, P Van Cauwenberge, N Khaltaev
Journal of allergy and clinical immunology 108 (5), S147-S334, 2001
54852001
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
T Zuberbier, W Aberer, R Asero, C Bindslev‐Jensen, Z Brzoza, ...
Allergy 69 (7), 868-887, 2014
3482*2014
Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
T Maurer, M., Rosén, K., Hsie, H. J., Saini, S
New Engl. J. Med., 2013
11712013
EAACI/GA²LEN/EDF/WAO guideline: management of urticaria
T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ...
Allergy 64 (10), 1427-1443, 2009
1078*2009
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report
M Maurer, K Weller, C Bindslev‐Jensen, A Giménez‐Arnau, PJ Bousquet, ...
Allergy 66 (3), 317-330, 2011
9862011
The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update
M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ...
World Allergy Organization Journal 11, 1-20, 2018
871*2018
Macrophage inflammatory protein-1
E Maurer, M., and von Stebuth
Int. J. Biochem. Cell. Biol. 36, 1882-1886, 2004
8662004
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs
J Bousquet, HJ Schünemann, B Samolinski, P Demoly, ...
Journal of Allergy and Clinical Immunology 130 (5), 1049-1062, 2012
8082012
EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria
T Zuberbier, R Asero, C Bindslev‐Jensen, G Walter Canonica, MK Church, ...
Allergy 64 (10), 1417-1426, 2009
7752009
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
A Kaplan, D Ledford, M Ashby, J Canvin, JL Zazzali, E Conner, J Veith, ...
Journal of Allergy and Clinical Immunology 132 (1), 101-109, 2013
6402013
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema
WT Cicardi, M., Banerji, A., Bracho, F., Malbrán, A
New Engl. J. Med. 363, 532-541, 2010
6392010
A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis
B Paus, R., Müller-Röver, S., Van Der Veen, C
Journal of Investigative Dermatology 113, 523-532, 1999
6261999
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
T Zuberbier, AH Abdul Latiff, M Abuzakouk, S Aquilina, R Asero, D Baker, ...
Allergy 77 (3), 734-766, 2022
6212022
Risk of first‐generation H1‐antihistamines: a GA2LEN position paper
MK Church, M Maurer, FER Simons, C Bindslev‐Jensen, ...
Allergy 65 (4), 459-466, 2010
5892010
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study
SS Saini, C Bindslev-Jensen, M Maurer, JJ Grob, EB Baskan, MS Bradley, ...
Journal of Investigative Dermatology 135 (1), 67-75, 2015
5132015
Mast cells as sentinels in innate immunity
CS Galli, S. J., Maurer, M., and Lantz
Curr. Opin. Immunol., 53-59, 1999
5001999
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria
S Saini, KE Rosen, HJ Hsieh, DA Wong, E Conner, A Kaplan, S Spector, ...
Journal of Allergy and Clinical Immunology 128 (3), 567-573. e1, 2011
4952011
How to assess disease activity in patients with chronic urticaria?
A Młynek, A Zalewska‐Janowska, P Martus, P Staubach, T Zuberbier, ...
Allergy 63 (6), 777-780, 2008
4742008
Epidemiology of urticaria: a representative cross‐sectional population survey
T Zuberbier, M Balke, M Worm, G Edenharter, M Maurer
Clinical and experimental dermatology 35 (8), 869-873, 2010
4592010
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
M Maurer, S Altrichter, T Bieber, T Biedermann, M Bräutigam, S Seyfried, ...
Journal of Allergy and Clinical Immunology 128 (1), 202-209. e5, 2011
4462011
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20